Last Price
0.071
Today's Change
+0.042 (144.82%)
Day's Change
0.067 - 0.08
Trading Volume
66,043,289
Market Cap
53 Million
Shares Outstanding
748 Million
Avg Volume
985,746
Avg Price (50 Days)
0.03
Avg Price (200 Days)
0.03
PE Ratio
-7.10
EPS
-0.01
Earnings Announcement
26-Aug-2025
Previous Close
0.03
Open
0.08
Day's Range
0.067 - 0.08
Year Range
0.019 - 0.08
Trading Volume
66,043,289
1 Day Change
144.83%
5 Day Change
144.83%
1 Month Change
153.57%
3 Month Change
222.73%
6 Month Change
77.50%
Ytd Change
86.84%
1 Year Change
75.97%
3 Year Change
28.25%
5 Year Change
-93.72%
10 Year Change
-93.72%
Max Change
-93.72%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.